|
Dr. Schultz is currently the Scripps Professor of Chemistry at The Scripps Research Institute and Director of the Genomics Institute of the Novartis Research Foundation (GNF). Dr. Schultz has made a number of major contributions to science including the discovery of catalytic antibodies, methodology that for the first time expands the genetic codes of living organisms, and the development and application of combinatorial methods in chemistry and biology including the first generation of combinatorial materials libraries. Dr. Schultz is a member of the National Academy of Sciences and the Institute of Medicine of the National Academy of Sciences. He is active on many editorial and scientific advisory boards and is a founding scientist of Affymax Research Institute and co-founder of Symyx Technologies, Syrrx, Kalypsys, Phenomix, Ilypsa, and Ambrx. | 